New York, Feb. 21, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Stem Cell Therapy Market Size, Share, Growth and Global Forecasts to 2028 - COVID-19 Impact and Global Analysis By Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes), and Geography”, the global stem cell therapy market size is growing from USD 2.27 billion in 2022 to USD 6.20 billion by 2028; it is estimated to grow at a CAGR of 18.2% from 2022 to 2028.
Download PDF Brochure at https://www.theinsightpartners.com/sample/TIPHE100000991
Global Stem Cell Therapy Market – Report Scope:
| Market Size Value in | USD 2.27 Billion in 2022 |
| Market Size Value by | USD 6.20 Billion by 2028 |
| Growth rate | CAGR of 18.2% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
| No. of Pages | 206 |
| No. of Tables | 138 |
| No. of Charts & Figures | 81 |
| Historical data available | Yes |
| Segments covered | Type, Treatment, Application, and End User |
Global Stem Cell Therapy Market: Competitive Landscape and Key Developments
Medipost; NuVasive Inc.; JCR Pharmaceuticals Co. Ltd.; AlloSource; Holostem Terapie Avanzate S.R.L.; Mesoblast Ltd.; U.S. Stem Cell, Inc.; Biotime, Inc.; RichSource; Caladrius; and TiGenix NV (Takeda Pharmaceuticals) are among the leading companies operating in the global stem cell therapy market. These players are focusing on expanding and diversifying their market presence and acquiring novel customer bases, thereby tapping prevailing business opportunities. Many players are launching innovative products in the stem cell therapy market with advanced features and cost-effective prices. A few of these product launches in the market are mentioned below.
In September 2022, Caladrius Biosciences, Inc. and Cend Therapeutics, Inc. announced the closedown of their merger, following the approval of Caladrius’ stockholders on September 13, 2022. The merged companies will operate as Lisata Therapeutics, Inc. The merger would primarily focus on advancing its CendR Platform technology product candidates against a range of oncology indications, in addition to Caladrius’ existing development programs.
In June 2021, the US Food and Drug Administration (FDA) granted Fast Track designation to ALLO-605, the next-generation AlloCAR T therapy offered by Allogene Therapeutics, Inc., targeting BCMA for the treatment of relapsed or refractory multiple myeloma. The designation was granted on the basis of the potential of ALLO-605 to address the unmet needs of patients who didn’t respond to other standard multiple myeloma therapies.
In June 2021, MEDIPOST announced the expansion of its facilities for knee osteoarthritis stem cell products—CARTISTEM and SMUP-IA-01. With this expansion, the company would start preparing for acquiring Good Manufacturing Practice (GMP) certification for its production facilities.
Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPHE100000991
Use of Induced Pluripotent Stem Cells in Regenerative Medicines Drives Global Stem Cell Therapy Market Growth:
Per the Frontiers Media S.A. 2023 report, progress in the field of induced pluripotent stem cells (iPSCs) has opened a new gateway for research in therapeutics. iPSCs are mainly intended for research and clinical studies such as disease modeling, regenerative medicine, and drug discovery/drug cytotoxicity studies. For example, iPSCs can be used to convert differentiated somatic cells to multipotent stem cells to generate different cell types of adult tissues. Thus, iPSCs have shown promising results in regenerative medicine, particularly for replacing diseased or injured cells. iPSCs are widely used to regenerate tissue-specific cells for transplantation procedures to treat injuries and degenerative diseases. Drug discovery and other studies involving the screening of small molecules and toxicity testing for safety assessment have successfully disclosed positive induced pluripotent stem cells (iPSCs) -based results. Thus, the use of induced pluripotent stem cells in regenerative medicines is expected to offer lucrative growth opportunities to companies in the stem cell therapy market in the coming years.
The stem cell therapy market growth is attributed to increasing research activities related to stem cell therapy for effective disease management and the growing prevalence of cancer.
Check Discount on this Report at https://www.theinsightpartners.com/discount/TIPHE100000991
Global Stem Cell Therapy Market - Type-Based Insights
Based on type, the stem cell therapy market is segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and other stem cell therapy. In 2022, the adult stem cell therapy segment accounted for the largest market share. The induced pluripotent stem cell therapy segment is expected to register the highest CAGR during the forecast period.
Global Stem Cell Therapy Market - Treatment -Based Insights
Based on treatment, the stem cell therapy market is bifurcated into allogeneic and autologous. In 2022, the allogenic segment held a larger market. Further, the autologous segment is expected to register a higher CAGR during the forecast period.
Global Stem Cell Therapy Market - Application-Based Insights
Based on application, the stem cell therapy market is categorized into musculoskeletal, dermatology, cardiology, drug discovery and development, and other applications. In 2022, the musculoskeletal segment held the largest share of the market. The drug discovery and development segment is expected to register the highest CAGR during the forecast period.
Global Stem Cell Therapy Market - End User-Based Insights
Based on end user, the stem cell therapy market is segmented into academic & research institutes and hospitals & clinics. The hospitals segment held a larger share of the market in 2022, and it is expected to record a higher CAGR during the forecast period.
Buy Premium Copy of Stem Cell Therapy Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPHE100000991
Browse other research published by The Insight Partners:
Global Stem Cell Manufacturing Market Size Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Stem Cell Lines, Instruments, Culture Media, Consumables); Application (Research Applications, Clinical Applications, Cell and Tissue Banking); End User (Pharmaceutical and Biotechnology Companies, Hospitals and Surgical Centers, Academic Institutes and Research Laboratories, CROs, Cell Banks and Tissue Banks)
Global Human Embryonic Stem Cell Market Size Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product Type (Totipotent Stem Cell, Pluripotent Stem Cell, Unipotent stem Cell); Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing); End User (Therapeutics Companies, Cell & Tissue Banks, Tools & Reagents Companies, Others) and Geography
Global Stem Cell Banking Market Size Forecast to 2028 - Covid-19 Impact and Global Analysis - by Source (Placental Stem Cells (PSCS), Dental Pulp-Derived Stem Cells (DPSCS), Bone Marrow-Derived Stem Cells (BMSCS), Adipose Tissue-Derived Stem Cells (ADSCS), Human Embryo-Derived Stem Cells (HESCS), and Other Stem Cell Sources), Service Type (Sample Preservation and Storage, Sample Analysis, Sample Processing, Sample Collection and Transportation), Application (Clinical Applications, Research Applications, and Personalized Banking Applications), and Geography
Global Mesenchymal Stem Cells Market Size Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Autologous, Allogeneic); Source (Bone Marrow, Cord Blood, Peripheral Blood, Fallopian Tube, Fetal liver, Lung, Adipose tissues); Indication (Bone and cartilage repair, Cardiovascular disease, Inflammatory and immunological diseases, Liver diseases, Cancer, GvHD); Application (Disease modeling, Drug development and discovery, Stem cell banking, Tissue engineering, Toxicology studies) and Geography
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Forecast to 2028 - Covid-19 Impact and Global Analysis - By Application (Neurodegenerative, Cardiovascular, Cancer and Autoimmune, Skin and Infectious Diseases); End User (Hospitals, Research Institutes) and Geography
Global Cell expansion Market Size - Global Analysis and Forecast - by Product (Consumables and Instruments); Cell Type (Human Cell and Animal Cell); Application (Regenerative Medicine & Stem Cell Research, Cancer and Cell-based Research, Other Applications); End User (Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks, and Other End Users)
Global Adipose Derived Stem Cell Therapy Market Size Forecast to 2028 - COVID-19 Impact and Global Analysis By Cell Type (Autologous Stem Cells, Allogeneic Stem Cells); Product (Cell Line, Culture Media); Disease (Cancer, Obesity, Wounds and Injuries, Musculoskeletal Diseases, Cardiovascular Diseases, Others); End User (Hospitals and Trauma Centers, Cell banks and Tissue Banks, Research Laboratories and Academic Institutes, Others) and Geography
Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Size Forecast to 2028 - Covid-19 Impact and Global Analysis - By Treatment (Stem Cell Therapy and Platelet Rich Plasma Therapies); End User (Dermatology Clinics, Hospitals and Other End Users) and Geography
Global Stem Cell Umbilical Cord Blood (UCB) Market Size Forecast to 2028 - COVID-19 Impact and Global Analysis By Storage Option (Private UCB Banks and Public UCB Banks); Disease (Bone Marrow Failure Syndrome, Immune Deficiencies, Leukemia, Lymphoma, Metabolic/Storage Diseases and Other Diseases) and Geography
Global Synthetic Stem Cells Market Size Forecast to 2028 - Covid-19 Impact and Global Analysis - by Application (Cardiovascular Diseases, Neurological Disorders, Other Applications)
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/stem-cell-therapy-market
